Drug intelligence / Profile preview

salicylic acid + piroctone olamine

Development stage
Unknown
Modality
Small Molecules
Administration
Topical
01

Overview

Salicylic acid + piroctone olamine is a topical combination therapy primarily used for the treatment of dandruff and seborrheic dermatitis of the scalp. Salicylic acid is a keratolytic agent that exfoliates and removes dead skin cells and flakes from the scalp, reducing scaling and facilitating penetration of other agents. Piroctone olamine is an antifungal compound that targets Malassezia species, the main pathogens involved in dandruff and seborrheic dermatitis, by disrupting fungal cell membranes and inhibiting fungal growth. The combination acts synergistically: salicylic acid clears scale and buildup, enabling piroctone olamine to more effectively reach and inhibit Malassezia, thereby controlling the underlying cause and symptoms of these scalp conditions. Clinically, this combination has demonstrated efficacy comparable to or slightly greater than that of zinc pyrithione-based shampoos, with noted improvements in flake reduction, symptom control, and scalp inflammation. Formulations containing this combination are most commonly found in medicated shampoos, scalp gels, or lotions for topical application[1][2][3][5][6][7].

Beyond the preview

Go deeper on salicylic acid + piroctone olamine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on salicylic acid + piroctone olamine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call